Generics in Germany

December 2024 | 42 pages | ID: G9455B614EFEN
MarketLine

Abstracts

Generics in Germany

Summary

Generics in Germany industry profile provides top-line qualitative and quantitative summary information including: market size (value 2018-23, and forecast to 2028). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights

• A generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and branded generics are included in our market scope. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the 'generic-eligible' market, are not included. Market value is evaluated at ex-factory prices. Market volume refers to the proportion of the total ethical pharmaceutical market in a country or region that is made up of generic drugs. Thus, it is a measure of the market share held by generics, rather than a direct measure of the total market volume. Regional volumes are calculated as averages of countries that comprise the region where volume data exists.
• The German generics market recorded revenues of $27.7 billion in 2023, representing a compound annual growth rate (CAGR) of 4.2% between 2018 and 2023.
• Market consumption volume increased with a CAGR of 1.5% between 2018 and 2023, to reach a total of 89.0% of total pharma volume in 2023.
• The German generics market is driven by the tax incentives for pharmaceutical research & development. For instance, in December 2023, the German Federal Government launched a National Pharmaceutical Strategy to promote a sustainable and internationally competitive pharmaceutical industry.

Scope

• Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the generics market in Germany
• Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the generics market in Germany
• Leading company profiles reveal details of key generics market players’ global operations and financial performance
• Add weight to presentations and pitches by understanding the future growth prospects of the Germany generics market with five year forecasts

Reasons to Buy

• What was the size of the Germany generics market by value in 2023?
• What will be the size of the Germany generics market in 2028?
• What factors are affecting the strength of competition in the Germany generics market?
• How has the market performed over the last five years?
• What are the main segments that make up Germany's generics market?

Contents

1 EXECUTIVE SUMMARY

1.1. Market value
1.2. Market value forecast
1.3. Market volume
1.4. Market volume forecast
1.5. Geography segmentation
1.6. Market rivalry
1.7. Competitive landscape

2 MARKET OVERVIEW

2.1. Market definition
2.2. Market analysis

3 MARKET DATA

3.1. Market value
3.2. Market volume

4 MARKET SEGMENTATION

4.1. Geography segmentation

5 MARKET OUTLOOK

5.1. Market value forecast
5.2. Market volume forecast

6 FIVE FORCES ANALYSIS

6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry

7 COMPETITIVE LANDSCAPE

7.1. Who are the leading players?
7.2. What are the strengths of the leading player?
7.3. Has the government recently implemented any initiatives aimed at boosting the market?

8 COMPANY PROFILES

8.1. Teva Pharmaceutical Industries Ltd
8.2. Novartis AG
8.3. Bayer AG
8.4. Stada Arzneimittel AG

9 MACROECONOMIC INDICATORS

9.1. Country data

10 APPENDIX

10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine